ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 128 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $298,000 | -55.5% | 6,375 | -65.7% | 0.03% | -60.5% |
| Q2 2017 | $669,000 | +17.0% | 18,584 | 0.0% | 0.08% | +35.7% |
| Q1 2017 | $572,000 | -51.4% | 18,584 | -65.2% | 0.06% | -64.1% |
| Q2 2016 | $1,178,000 | -53.0% | 53,415 | -37.3% | 0.16% | -48.5% |
| Q1 2016 | $2,504,000 | +95.2% | 85,258 | +119.5% | 0.30% | +89.4% |
| Q4 2015 | $1,283,000 | +6.3% | 38,843 | +16.3% | 0.16% | -2.4% |
| Q3 2015 | $1,207,000 | -16.2% | 33,400 | +4.4% | 0.16% | -33.1% |
| Q2 2015 | $1,440,000 | +372.1% | 32,000 | +221.5% | 0.24% | +202.5% |
| Q1 2015 | $305,000 | – | 9,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |